Enduring Activity

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 6.75 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Array BioPharma, Inc.; Bristol-Myers Squibb; Genentech, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.

16th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

16th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2020

InterContinental New York Times Square

300 W 44th St.
New York, NY 10036


PER®’s 16th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a single-day educational conference discussing emerging treatments in melanoma, basal cell carcinoma, squamous cell carcinoma, and Merkel cell carcinoma. This concise and engaging program will inform your practice with insights from world-renowned experts on evolving standards of care in melanoma and other cutaneous malignancies.

Chairs Jeffrey S. Weber, MD, PhD, and Omid Hamid, MD, are the world-renowned experts leading this international program. This fast-paced and interactive forum provides the most concise and complete update for physicians who treat skin cancers. With unmatched access to leading experts in the field, this program provides a forum for improving clinical practice and enables participants to apply the latest research into clinical practice. Sessions will cover the latest advances in immuno-oncology, targeted therapies, regional therapies, and the value of using predictive and prognostic biomarkers. With a special focus on treatment-related adverse event management, this program promises to provide actionable points to improve outcomes for your patients. With dynamic and interactive Medical Crossfire® discussions, experts will debate key questions in the field and develop evidence-based answers to inform your practice.

One-stop, one day, application

What you will learn:

  • The current use of checkpoint inhibitors and other immunotherapeutic strategies, including intralesional therapies, both as single-agent therapy and in combination with other regimens
  • Insights into emerging therapeutic targets, including agents targeting LAG3, STING, and other pathways
  • Best practices for use of BRAF/MEK inhibitors as single-agent therapy and in combination with other therapies
  • Management strategies in the setting of regional disease and metastatic disease
  • Strategies for the mitigation of potential adverse events with targeted treatments and checkpoint inhibitors

Benefits of Attending

  • Interact with top experts in the field of cutaneous malignancies
  • Gain actionable insights to improve the treatment of your patients
  • Recognize the role of targeted therapies, checkpoint inhibitors, and combination therapies across the cutaneous malignancies
  • Recognize current best practices for management of adverse events with targeted therapies and checkpoint inhibitors
  • Network with colleagues and peers

Target Audience

This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate.

Learning Objectives

At the conclusion of this symposium, you should be better prepared to:

  • Recognize best practices from the latest clinical trials in cutaneous malignancies to manage the full range of cutaneous malignancies across stages of disease
  • Understand best practice for multidisciplinary identification and management of the adverse events associated with treatment across cutaneous malignancies
  • Outline best practices for use of biomarkers in personalizing care in patients with melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and other cutaneous malignancies
  • Contextualize current evidence in terms of evolving standards of care to support the optimal sequencing of therapies across melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and other cutaneous malignancies

Acknowledgment of Commercial Support

This activity is supported by educational grants from Array BioPharma, Inc.; Bristol-Myers Squibb; Genentech, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.

Program Co-Chairs

Omid Hamid
Omid Hamid, MD
Chief, Translational Research and Immuno-Oncology
Director, Cutaneous Malignancies
The Angeles Clinic and Research Institute
Director, Experimental Therapeutics
Cedars Sinai Medical Care Foundation
Los Angeles, CA
Jeffrey S. Weber
Jeffrey S. Weber, MD, PhD
Deputy Director
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU Langone Medical Center
New York, NY


Registration fees include continental breakfast, breaks, and e-syllabus materials.

2 Ways to Register
  1. Online: Click here.
  2. Phone:  Please call (888) 949-0045 or (609) 378-3701 (credit cards only).
Physicians' Education Resource - IME20
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
Registration Fees
  Advance On-Site
Physicians $99 $149
Fellows* $49 $99
Nurses, PAs, Other Health Care Professionals $49 $99
Industry** $229 $279
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.
A cancellation fee of 25% will be assessed on refunds requested prior to January 11, 2019, and a 50% fee on refunds requested on January 12, 2019, through February 1, 2019. No refunds will be made after February 1, 2019. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image").  By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19

I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.

I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.

* By checking this box, you have read and understand the above and agree to its terms.

Calendar of Events
Filter By